CHUNG KWANG HOE has a total of 12 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Republic of Korea, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are REBER GENETICS CO LTD, MOLMED SPA and VLP THERAPEUTICS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 6 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | China | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Microbiology | |
#7 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Chung Kwang Hoe | 7 |
#2 | Hong Sung-Yu | 4 |
#3 | Son Yeong Deok | 4 |
#4 | Jang Yang Su | 4 |
#5 | Chung Kwang-Hoe | 3 |
#6 | Huh Chin-Kyu | 3 |
#7 | Jang Yang-Soo | 3 |
#8 | Hong Seong Yu | 3 |
#9 | Kim Doo-Sik | 3 |
#10 | Kim Du Sik | 3 |
Publication | Filing date | Title |
---|---|---|
KR20040066376A | Pharmaceutical Composition for Treating Restenosis Comprising Cordycepin as Active Ingredient | |
KR20030018735A | Methods for mass production of protein repressing tumor cells growth | |
CN1545424A | Anti-cancer medicine comprising disintegrin genes and treating methods thereof | |
KR20030019674A | Anti-cancer agents comprising disintegrin genes and the treating methods | |
EP1303592A1 | Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same | |
KR20020064787A | Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same | |
KR20020081601A | Factor Xa Inhibiting Protein and the Process for Preparing the Same | |
KR100247151B1 | A refolding system for recombinant proteins expressed in escherichia coli as inclusion bodies |